Martin Fan
Stock Analyst at Wedbush
(4.88)
# 166
Out of 5,182 analysts
25
Total ratings
68.18%
Success rate
74.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Maintains: Neutral | $9 → $15 | $15.47 | -3.04% | 2 | Mar 31, 2026 | |
| ACRS Aclaris Therapeutics | Reiterates: Outperform | $8 | $4.04 | +98.02% | 2 | Mar 31, 2026 | |
| NKTR Nektar Therapeutics | Initiates: Neutral | $70 | $77.50 | -9.68% | 1 | Mar 24, 2026 | |
| ORKA Oruka Therapeutics | Reiterates: Outperform | $45 | $59.58 | -24.47% | 3 | Mar 13, 2026 | |
| ANAB AnaptysBio | Maintains: Outperform | $60 → $75 | $70.10 | +6.99% | 6 | Mar 12, 2026 | |
| RNAC Cartesian Therapeutics | Reiterates: Outperform | $38 | $5.98 | +535.45% | 2 | Mar 10, 2026 | |
| ZURA Zura Bio | Initiates: Outperform | $15 | $5.65 | +165.49% | 1 | Feb 9, 2026 | |
| ZBIO Zenas BioPharma | Reiterates: Outperform | $45 | $20.44 | +120.16% | 3 | Dec 22, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $4.90 | -59.20% | 1 | Nov 25, 2025 | |
| SANA Sana Biotechnology | Maintains: Outperform | $5 → $6 | $3.09 | +94.17% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $23 | $6.81 | +237.74% | 2 | Oct 17, 2025 |
Vor Biopharma
Mar 31, 2026
Maintains: Neutral
Price Target: $9 → $15
Current: $15.47
Upside: -3.04%
Aclaris Therapeutics
Mar 31, 2026
Reiterates: Outperform
Price Target: $8
Current: $4.04
Upside: +98.02%
Nektar Therapeutics
Mar 24, 2026
Initiates: Neutral
Price Target: $70
Current: $77.50
Upside: -9.68%
Oruka Therapeutics
Mar 13, 2026
Reiterates: Outperform
Price Target: $45
Current: $59.58
Upside: -24.47%
AnaptysBio
Mar 12, 2026
Maintains: Outperform
Price Target: $60 → $75
Current: $70.10
Upside: +6.99%
Cartesian Therapeutics
Mar 10, 2026
Reiterates: Outperform
Price Target: $38
Current: $5.98
Upside: +535.45%
Zura Bio
Feb 9, 2026
Initiates: Outperform
Price Target: $15
Current: $5.65
Upside: +165.49%
Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $20.44
Upside: +120.16%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $4.90
Upside: -59.20%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5 → $6
Current: $3.09
Upside: +94.17%
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $6.81
Upside: +237.74%